These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 12293313)
1. [Our regions evaluate the program. Contraception by injectable progestin, Depo Provera: opportunity, continuity and analyses of the situation in central west Tunisia]. Khelifi A Majallat Aldiwan Alqawmi Lilusrah Waal Umran lbashari; 1997 Sep; (6):16-7. PubMed ID: 12293313 [TBL] [Abstract][Full Text] [Related]
2. Acceptability study of the two versus three monthly injectable contraceptives. Aly FA; El-genedi MM; Toppozada HK; El-abd M; Loutfi I Dirasat Sukkaniyah; 1984; 11(69):27-39. PubMed ID: 12179796 [TBL] [Abstract][Full Text] [Related]
4. [Prolonged use of medroxyprogesterone acetate for contraception]. Pena Delgado J; Aleman Herrera M; Baez Reyes A Sem Med Mex; 1981 Jun; 98(11):331-50. PubMed ID: 12279435 [TBL] [Abstract][Full Text] [Related]
5. Cyclofem shoots into injectable market. Family Plan World; 1992; ():19. PubMed ID: 12290896 [TBL] [Abstract][Full Text] [Related]
6. Introducing more contraceptive methods in Jordan. Gallagher M AVSC News; 1998; 36(1):3, 8. PubMed ID: 12321883 [TBL] [Abstract][Full Text] [Related]
7. Use of a long-acting injectable contraceptive in a postpartum family planning program. Mcdaniel EB; Pardthaisong T Asian J Med; 1973 Apr; 9(4):133-5. PubMed ID: 12262537 [TBL] [Abstract][Full Text] [Related]
8. Depo-Provera use in Sri Lanka: acceptor characteristics, continuation and side effects. Basnayake S; Thapa S Adv Contracept Deliv Syst; 1986 Oct; 2(4):307-21. PubMed ID: 12341188 [TBL] [Abstract][Full Text] [Related]
9. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception. London RS J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530 [TBL] [Abstract][Full Text] [Related]
10. Injectable contraception. International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP IPPF Med Bull; 1980 Dec; 14(6):1-3. PubMed ID: 12310087 [TBL] [Abstract][Full Text] [Related]
12. [Study on Norplant carried out by the Gabes regional committee]. Bull Assoc Tunis Plan Fam; 1995; (35):4-5. PubMed ID: 12290883 [TBL] [Abstract][Full Text] [Related]
13. FDA gives final approval to Depo amid concerns over safety, cost and coercion. Wash Memo Alan Guttmacher Inst; 1992 Nov; (17):2-3. PubMed ID: 12344620 [TBL] [Abstract][Full Text] [Related]
14. Depo-Provera use in an Australian metropolitan practice. Fraser IS; Dennerstein GJ Med J Aust; 1994 May; 160(9):553-6. PubMed ID: 8164553 [TBL] [Abstract][Full Text] [Related]
15. Depo-Provera -- proving its innocence. Choudhury IR Indian Med Trib; 1994 Jul; 2(11):5. PubMed ID: 12179187 [TBL] [Abstract][Full Text] [Related]
17. Extracts from the report on the Joint IGCC/IFRP East and South East Asia Seminar on Regional Fertility Research. Mcdaniel EB IGCC News; 1980 Jan; 5(3):1-4. PubMed ID: 12179403 [TBL] [Abstract][Full Text] [Related]
19. The pituitary reserve for gonadotrophins and prolactin in women under long-term use of depo-medroxyprogesterone acetate (DMPA) as a contraceptive. Mukasa FR; Sekadde-kigondu CB; Mati JK; Njoroge JK J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):160-3. PubMed ID: 12313677 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and acceptability of depo-medroxyprogesterone acetate injection. As a method of contraception in Saudi Arabia. Sobande AA; Al-Bar HM; Archibong EI; Sadek AA Saudi Med J; 2000 Apr; 21(4):348-51. PubMed ID: 11533816 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]